As of Aug 24
| -0.01 / -0.05%|
The 4 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 21.75, with a high estimate of 21.75 and a low estimate of 15.00. The median estimate represents a +0.09% increase from the last price of 21.73.
The current consensus among 6 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.